| Basics |
|
Precigen, Inc.
|
| IPO Date: |
August 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.44B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 4.26%
|
| Avg Daily Range (30 D): |
$0.15 | 4.13%
|
| Avg Daily Range (90 D): |
$0.12 | 4.07%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.57M |
| Avg Daily Volume (30 D): |
5.26M |
| Avg Daily Volume (90 D): |
6.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
214 |
| Avg Trade Size (Sh.) (30 D): |
237 |
| Avg Trade Size (Sh.) (90 D): |
283 |
| Institutional Trades |
| Total Inst.Trades: |
410 |
| Avg Inst. Trade: |
$1.48M |
| Avg Inst. Trade (30 D): |
$1.46M |
| Avg Inst. Trade (90 D): |
$1.33M |
| Avg Inst. Trade Volume: |
.34M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.54M |
| Avg Closing Trade (30 D): |
$1.4M |
| Avg Closing Trade (90 D): |
$1.38M |
| Avg Closing Volume: |
350.2K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.42
|
$-.09
|
$-.18
|
|
Diluted EPS
|
$-.42
|
$-.09
|
$-.18
|
|
Revenue
|
$
|
$
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -124.5M
|
$ -26.64M
|
$ -54.15M
|
|
Operating Income / Loss
|
$
|
$
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 4.15M
|
$ 7.7M
|
$ -23.46M
|
|
PE Ratio
|
|
|
|
|
|
|